These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 11243382)
1. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice. Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382 [TBL] [Abstract][Full Text] [Related]
2. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552 [TBL] [Abstract][Full Text] [Related]
3. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354 [TBL] [Abstract][Full Text] [Related]
4. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630 [TBL] [Abstract][Full Text] [Related]
5. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195 [TBL] [Abstract][Full Text] [Related]
6. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065 [TBL] [Abstract][Full Text] [Related]
7. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806 [TBL] [Abstract][Full Text] [Related]
9. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Ono Y; Fukuhara N; Yoshie O Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382 [TBL] [Abstract][Full Text] [Related]
10. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development. Robb L; Begley CG Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726 [TBL] [Abstract][Full Text] [Related]
11. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269 [TBL] [Abstract][Full Text] [Related]
12. Generation of Inducible Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322 [TBL] [Abstract][Full Text] [Related]
14. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. O'Neil J; Billa M; Oikemus S; Kelliher M Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353 [TBL] [Abstract][Full Text] [Related]
15. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Gering M; Yamada Y; Rabbitts TH; Patient RK Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685 [TBL] [Abstract][Full Text] [Related]
16. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. Elwood NJ; Cook WD; Metcalf D; Begley CG Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Lin YW; Aplan PD Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429 [TBL] [Abstract][Full Text] [Related]
18. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis. Robb L; Begley CG Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693 [TBL] [Abstract][Full Text] [Related]
19. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958 [TBL] [Abstract][Full Text] [Related]
20. NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis. Göthert JR; Brake RL; Smeets M; Dührsen U; Begley CG; Izon DJ Blood; 2007 Nov; 110(10):3753-62. PubMed ID: 17698635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]